Key Takeaways

  • GLP-1 drugs offer a multi-faceted approach to health, potentially aiding in weight loss, reducing blood sugar levels, lowering cardiovascular risks, and possibly treating addictive behaviors, with a massive market opportunity forecasted at $60 billion by 2030

  • The adoption of GLP-1 drugs for obesity treatment is likely to increase due to changing perceptions of obesity as a chronic medical condition, improving insurance coverage, advancements in treatment options, and the feasibility of long-term use

  • The widespread use of GLP-1 drugs could have far-reaching impacts beyond the healthcare sector, potentially affecting industries like apparel, gaming, and airlines by altering consumer behavior and bringing about shifts in market valuations

We’ve all heard a lot of hype about Glucagon-Like Peptide-1, or better known as GLP-1s. These weight-loss drugs have been making headlines and captivating the attention of those who are looking to lose weight and improve their health. 

Watch Jordan Grant, Director, Business Development, and Chulantha De Silva, Client Portfolio Manager, as they discuss the opportunities GLP-1s are bringing to the marketplace and how the target market is expanding as the medicines convert from a shot to a pill form. They also explore the downstream impacts of the drugs on other sectors outside of the healthcare industry.    

Views and opinions are expressed as of November 29th, 2023.

There may be additional risks associated with international and emerging markets investing involving foreign, economic, political, monetary, and/or legal factors. International investing is not for everyone. You can lose money by investing in securities.

The information provided in this video does not constitute investment advice and no investment decision should be made based on it. Neither the information contained in this video or in any accompanying oral presentation is a recommendation to follow any strategy or allocation. In addition, neither is a recommendation, offer or solicitation to sell or buy any security or to purchase of shares in any fund or establish any separately managed account. It should not be assumed that any investments made by GQG Partners LLC (GQG) in the future will be profitable or will equal the performance of any securities discussed herein. Before making any investment decision, you should seek expert, professional advice, including tax advice, and obtain information regarding the legal, fiscal, regulatory and foreign currency requirements for any investment according to the law of your home country, place of residence or current abode.

This video reflects the views of GQG as of a particular time. GQG’s views may change without notice. Any forward-looking statements or forecasts are based on assumptions and actual results may vary.

GQG provides this information for informational purposes only. GQG has gathered the informati

ion in good faith from sources it believes to be reliable, including its own resources and third parties. However, GQG does not represent or warrant that any information, including, without limitation, any past performance results and any third-party information provided, is accurate, reliable or complete, and it should not be relied upon as such. GQG has not independently verified any information used or presented that is derived from third parties, which is subject to change. Information on holdings, allocations, and other characteristics is for illustrative purposes only and may not be representative of current or future investments or allocations.

The information contained in this video is unaudited. It is published for the assistance of recipients, but is not to be relied upon as authoritative and is not to be substituted for the exercise of one’s own judgment. GQG is not required to update the information contained in these materials, unless otherwise required by applicable law.

No portion of this video may be reproduced, quoted or distributed without the prior written consent of GQG. GQG is registered as an investment adviser with the U.S. Securities and Exchange Commission. Please see GQG’s Form ADV Part 2, which is available upon request, for more information about GQG.

Any account or fund advised by GQG involves significant risks and is appropriate only for those persons who can bear the economic risk of the complete loss of their investment. There is no assurance that any account or fund will achieve its investment objectives. Accounts and funds are subject to price volatility and the value of a portfolio will change as the prices of investments go up or down. Before investing in a strategy, you should consider the risks of the strategy as well as whether the strategy is appropriate based upon your investment objectives and risk tolerance.

GQG Partners LLC is a wholly owned subsidiary of GQG Partners Inc., a Delaware corporation that is listed on the Australian Securities Exchange.

© 2023 GQG Partners LLC. All rights reserved.